120 related articles for article (PubMed ID: 32766728)
1. Cytomegalovirus esophagitis in a patient on ocrelizumab therapy: A case report.
Miller AA; Mathew D; Huot C
Am J Health Syst Pharm; 2020 Aug; 77(16):1278-1279. PubMed ID: 32766728
[No Abstract] [Full Text] [Related]
2. Ocrelizumab-induced colitis and cytomegalovirus infection and their disadvantageous interaction with underlying multiple sclerosis.
Lieb S; Heni M; Rauschenberg S; Lange K; Feisthammel J; Bläker H; Wiegand J
Z Gastroenterol; 2023 Nov; 61(11):1500-1503. PubMed ID: 36736346
[TBL] [Abstract][Full Text] [Related]
3. Active CMV infection in two patients with multiple sclerosis treated with alemtuzumab.
Clerico M; De Mercanti S; Artusi CA; Durelli L; Naismith RT
Mult Scler; 2017 May; 23(6):874-876. PubMed ID: 28290755
[TBL] [Abstract][Full Text] [Related]
4. Esophageal and gastric ulceration due to synchronous herpes simplex virus, cytomegalovirus and Epstein-Barr virus infection.
Peixoto A; Santos-Antunes J; Silva M; Macedo G
Acta Gastroenterol Belg; 2016; 79(2):271-2. PubMed ID: 27382954
[No Abstract] [Full Text] [Related]
5. Herpes and cytomegalovirus esophagitis.
Albuquerque A; Cardoso H; Ribeiro A; Rios E; Silva R; Magalhães J; Macedo G
Endoscopy; 2012; 44 Suppl 2 UCTN():E242-3. PubMed ID: 22715014
[No Abstract] [Full Text] [Related]
6. Cytomegalovirus-esophagitis as initial presentation of HIV infection mimicking adenocarcinoma.
Weinberg G; Siegmund B; Grünbaum M; Loddenkemper C; Schneider T
Endoscopy; 2010; 42 Suppl 2():E22-3. PubMed ID: 20073003
[No Abstract] [Full Text] [Related]
7. Early post-transplant diagnosis of cytomegalovirus esophagitis in an ABO-incompatible kidney transplant recipients: A case report.
Yazawa M; Sasaki H; Sakurai Y; Kudo H; Nakazawa R; Chikaraishi T; Shibagaki Y
Transpl Infect Dis; 2018 Apr; 20(2):e12827. PubMed ID: 29277957
[TBL] [Abstract][Full Text] [Related]
8. Ocrelizumab: A New B-cell Therapy for Relapsing Remitting and Primary Progressive Multiple Sclerosis.
Stahnke AM; Holt KM
Ann Pharmacother; 2018 May; 52(5):473-483. PubMed ID: 29232960
[TBL] [Abstract][Full Text] [Related]
9. An unusual case of dysphagia.
Crinò SF; Marino R; Buscarini E; Leoni P
Dig Liver Dis; 2012 May; 44(5):e9. PubMed ID: 22281377
[No Abstract] [Full Text] [Related]
10. Long-term follow-up from the ORATORIO trial of ocrelizumab for primary progressive multiple sclerosis: a post-hoc analysis from the ongoing open-label extension of the randomised, placebo-controlled, phase 3 trial.
Wolinsky JS; Arnold DL; Brochet B; Hartung HP; Montalban X; Naismith RT; Manfrini M; Overell J; Koendgen H; Sauter A; Bennett I; Hubeaux S; Kappos L; Hauser SL
Lancet Neurol; 2020 Dec; 19(12):998-1009. PubMed ID: 33129442
[TBL] [Abstract][Full Text] [Related]
11. Esophagitis Caused by Cytomegalovirus Infection in an Immune-competent Patient.
Hashimoto R; Chonan A
Clin Gastroenterol Hepatol; 2016 Dec; 14(12):e143-e144. PubMed ID: 27374005
[No Abstract] [Full Text] [Related]
12. Cytomegalovirus esophagitis in an immunocompetent patient: case report.
Lim DS; Lee TH; Jin SY; Lee JS
Turk J Gastroenterol; 2014 Oct; 25(5):571-4. PubMed ID: 25417622
[TBL] [Abstract][Full Text] [Related]
13. A Fluttering Blue Hue Is Tough to Subdue.
Hoppmann N; Weber F
Gastroenterology; 2019 Apr; 156(5):1255-1256. PubMed ID: 30610860
[No Abstract] [Full Text] [Related]
14. Ulcerative colitis and cytomegaloviral esophagitis: two diseases, two randomized, controlled trials.
Surawicz CM
Curr Gastroenterol Rep; 1999 Aug; 1(4):280-1. PubMed ID: 10980961
[No Abstract] [Full Text] [Related]
15. Cytomegalovirus esophagitis in nonimmunocompromised patient--presenting as an acute necrotic (black) esophagitis.
Yagain K; Rao L; Pai K; Pai G
Indian J Pathol Microbiol; 2011; 54(4):852-3. PubMed ID: 22234138
[No Abstract] [Full Text] [Related]
16. Reduction in ocrelizumab-induced infusion reactions by a modified premedication protocol.
Conte WL; Arndt N; Cipriani VP; Dellaria A; Javed A
Mult Scler Relat Disord; 2019 Jan; 27():397-399. PubMed ID: 30508784
[TBL] [Abstract][Full Text] [Related]
17. Predicting Infection Risk in Multiple Sclerosis Patients Treated with Ocrelizumab: A Retrospective Cohort Study.
Seery N; Sharmin S; Li V; Nguyen AL; Meaton C; Atvars R; Taylor N; Tunnell K; Carey J; Marriott MP; Buzzard KA; Roos I; Dwyer C; Baker J; Taylor L; Spriggs K; Kilpatrick TJ; Kalincik T; Monif M
CNS Drugs; 2021 Aug; 35(8):907-918. PubMed ID: 33847902
[TBL] [Abstract][Full Text] [Related]
18. Severe Bleeding due to Cytomegalovirus Esophagitis in a Patient with Diabetes after Interbody Fusion Surgery.
Yamamoto S; Iwamuro M; Miyake M; Nishimura N; Mizuno M; Okada H
Intern Med; 2019 Oct; 58(20):2949-2955. PubMed ID: 31292384
[TBL] [Abstract][Full Text] [Related]
19. Two cases of meningitis associated with ocrelizumab therapy.
Theriault M; Solomon AJ
Mult Scler Relat Disord; 2020 Feb; 38():101866. PubMed ID: 31821962
[TBL] [Abstract][Full Text] [Related]
20. Cytomegalovirus infection of esophagus in immunocompetent adult.
Altman C; Bedossa P; Dussaix E; Buffet C
Dig Dis Sci; 1995 Mar; 40(3):606-8. PubMed ID: 7895553
[No Abstract] [Full Text] [Related]
[Next] [New Search]
